Edap Tms (EDAP) Given Daily Media Impact Rating of 0.19

Share on StockTwits

News stories about Edap Tms (NASDAQ:EDAP) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Edap Tms earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.18936643813 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

Edap Tms remained flat at $$3.14 during mid-day trading on Friday, Marketbeat Ratings reports. The company had a trading volume of 19,752 shares, compared to its average volume of 63,877. The stock has a market capitalization of $91.05 million, a PE ratio of -314.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.04 and a current ratio of 2.45. Edap Tms has a 12 month low of $2.07 and a 12 month high of $4.25.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Monday, May 14th. The medical equipment provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.05. The company had revenue of $11.28 million during the quarter, compared to analysts’ expectations of $10.46 million. Edap Tms had a negative return on equity of 5.89% and a negative net margin of 5.98%. equities research analysts anticipate that Edap Tms will post -0.01 EPS for the current fiscal year.

A number of analysts recently commented on the company. ValuEngine upgraded Edap Tms from a “hold” rating to a “buy” rating in a research report on Monday, July 16th. HC Wainwright reiterated a “buy” rating and set a $6.50 price objective on shares of Edap Tms in a research report on Monday, July 2nd. Finally, TheStreet upgraded Edap Tms from a “d+” rating to a “c” rating in a research report on Tuesday, June 26th.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

See Also: Trading Penny Stocks

Insider Buying and Selling by Quarter for Edap Tms (NASDAQ:EDAP)

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.